Helen Ajufo, MD, MS¹, Andriy Derkach, PhD^2*, Raajit K. Rampal, MD, PhD¹, Christopher Famulare, MS^1*, David Nemirovsky, MS^2*, Jordan Chervin^3*, Vincent Ho, MD^4*, Vikas Gupta, MD⁵, Auro Viswabandya, MD⁶, H. Joachim Deeg, MD⁷, Tim Monahan^7*, Tania Jain, MD⁸, Richard J. Jones, MD⁸, Jeanne Palmer, MD⁹, Aaron T. Gerds, MD, MS¹⁰, Alla Keyzner, MD¹¹, Jonathan Lagdameo^12*, Alexandra Gomez-Arteaga, MD¹³, Koen Van Besien, MD, PhD¹⁴, Nikolai A. Podoltsev, MD, PhD¹⁵, Christian Puzo^16*, Satyajit Kosuri, MD^17*, Idoroenyi Amanam, MD¹⁸ and Roni Tamari, MD^1*

¹Memorial Sloan Kettering Cancer Center, New York, NY
²Department of Biostatistics and Epidemiology, Memorial Sloan Kettering Cancer Center, New York, NY
³Weill Cornell, New York, NY
⁴Dana-Farber Cancer Institute, Boston, MA
⁵Leukemia Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
⁶Princess Margaret Cancer Centre, Toronto, Canada
⁷Fred Hutchinson Cancer Research Center, Seattle, WA
⁸Johns Hopkins University, Baltimore, MD
⁹Mayo Clinic - Arizona, Scottsdale, AZ
¹⁰Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
¹¹Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York
¹²Mount Sinai, New York
¹³NewYork-Presbyterian/Weill Cornell Medicine, New York
¹⁴University Hospitals Seidman Cancer Center, Cleveland, OH
¹⁵Associate Professor of Medicine, Department of Hematology, Yale School of Medicine, New Haven, CT
¹⁶Yale School of Medicine, New Haven, CT
¹⁷University of Chicago Medicine, Chicago, IL
¹⁸Department of Hematologic Malignancies Translational Science, Gehr Family Center for Leukemia Research, City of Hope National Medical Center and Beckman Research Institute, Duarte, CA

Ruben A. Mesa, MD¹, Andrew C. Perkins, MBBS, PhD², Yeow Tee Goh, MBBS³, Maria Laura Fox, MD^4*, Donal P McLornan, MD, PhD^5*, Jeanne Palmer, MD⁶, Lynda Foltz, MD⁷, Alessandro Maria Vannucchi⁸, Steffen Koschmieder⁹, Francesco Passamonti, MD^10*, Sung-Eun Lee, MD^11*, Jun Kawashima, MD^12*, Bryan Strouse, MS^13*, Francisco Gonzalez Carreras, MS, PhD^14* and Stephen T. Oh, MD, PhD¹⁵

¹Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, NC
²Monash University, Melbourne, Australia
³SingHealth Duke-NUS Blood Cancer Center and Singapore General Hospital, Singapore, Singapore
⁴Vall d'Hebron University Hospital, Barcelona, Spain
⁵University College London Hospitals NHS Trust, London, United Kingdom
⁶Mayo Clinic - Arizona, Phoenix, AZ
⁷St. Paul’s Hospital, University of British Columbia, Vancouver, BC, Canada
⁸University of Florence, Florence, Italy
⁹9RWTH Aachen University and Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD), Aachen, Germany
¹⁰University of Milano Statale, Milano, Italy
¹¹Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul, Korea, Republic of (South)
¹²Sierra Oncology, San Mateo, CA
¹³GSK plc, Collegeville, PA
¹⁴GlaxoSmithKline, Stevenage, United Kingdom
¹⁵Department of Medicine, Washington University School of Medicine, Saint Louis, MO

Natasha Szuber, MD, MSc^1,2, Steve Dagenais-Bellefeuille, MD^2*, Mégane Tanguay, MD², Awatef Shehabeldeen, MD^3*, Saima Ahmed, MD^4*, Michaël Harnois^1*, Jaroslav F. Prchal, MD³, Harold J. Olney^1,5*, Lambert Busque, MD^1,2 and Shireen Sirhan, MD, FRCP^1,6,7

¹Quebec CML-MPN Research Group, Montreal, QC, Canada
²University of Montreal, Montreal, QC, Canada
³St-Mary’s Hospital, Montreal, QC, Canada
⁴Division of Experimental Medicine, Faculty of Medicine and Health Sciences, McGill University, Montreal, QC, Canada
⁵Centre Hospitalier de l'Université de Montréal, Montreal, QC, CAN
⁶Segal Cancer Center, Jewish General Hospital, Montreal, QC, Canada
⁷McGill University, Montreal, QC, Canada

Sandra Huber, PhD^*, Gregor Hoermann, MD, PhD, Manja Meggendorfer, PhD, Stephan Hutter, PhD^*, Constance Regina Baer, PhD, Wolfgang Kern, MD, Torsten Haferlach, MD, PhD and Claudia Haferlach, MD

MLL Munich Leukemia Laboratory, Munich, Germany

Claire N Harrison¹, David M. Ross, MBBS, PhD, FRACP, FRCPA^2*, Lynette C.Y. Chee, MBBS, PhD, FRACP, FRCPA³, Shuhying Tan, FRACP, FRCPA, MBBS^4*, Marielle Wondergem, MD, PhD⁵, Timothy Devos, MD^6*, Christine Graham, PhD^7*, Allie McGinty^7*, Michael Pace^7*, Hongying Wang^7*, Ying Jiang^7*, Suresh Bobba^7*, Katie Louise Dawson^7*, Christopher Rovaldi^7*, Montagu Hankin, MSc^7*, Dena Grayson, MD, PhD^7*, Simon Cooper, MBBS⁷ and Jen L. Salstrom, MD, PhD⁷

¹Guy’s and St. Thomas’ NHS Foundation Trust, London, ENG, United Kingdom
²Department of Haematology, Flinders Medical Centre and University, Adelaide, SA, Australia
³Department of Clinical Haematology and Bone Marrow Transplant Service, The Royal Melbourne Hospital, Parkville, Australia
⁴St. Vincent's Institute of Medical Research, East Melbourne, Vic, AUS
⁵Department of Hematology, Amsterdam University Medical Centers, Amsterdam, Netherlands
⁶Department of Hematology, University Hospitals Leuven, Leuven, Belgium
⁷Keros Therapeutics, Lexington, MA

Spencer Krichevsky, MS^1,2*, Ghaith Abu-Zeinah, MD², Katie Erdos^2* and Joseph M. Scandura, MD, PhD, MS²

¹Department of Biomedical Informatics, Stony Brook University, Stony Brook, NY
²Richard T. Silver, MD Myeloproliferative Neoplasms Center, Weill Cornell Medicine, New York, NY

Julian Waksal, MD¹, Ronald Hoffman, MD², Abdulraheem Yacoub, MD^3,4, Francesco Passamonti, MD^5*, Aaron T. Gerds, MD, MS⁶, Vikas Gupta, MD⁷, Grace Van Hyfte^8*, Jayanshu Jain, MD⁹, Margherita Maffioli^10*, Natalia Rosas^11* and John Mascarenhas, MD^1*

¹Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY
²Department of Medicine, Division of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY
³The University of Kansas Medical Center, Leawood, KS
⁴The University of Kansas, Westwood, KS
⁵Ospedale Di Circolo E Fondazione Macchi, Varese, ITA
⁶Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
⁷Leukemia Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
⁸Tisch Cancer Institute, The Mount Sinai Hospital, New York, NY
⁹Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Westwood, KS
¹⁰ASST Dei Sette Laghi, Ospedale Di Circolo, Varese, Varese, ITA
¹¹Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH

Vikas Gupta, MD¹, Claire N Harrison², Boris Gorsh, PharmD^3*, Bharat Patel, BSc^3*, Zhaohui Wang, MS^4*, Molly Purser, PhD, MBA^3*, Catherine Ellis, BS^4*, Bryan Strouse, MS^3*, Dwaipayan Patnaik, MD, MBBS⁵, Jun Kawashima, MD^6* and Ruben A. Mesa, MD⁷

¹Leukemia Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
²Guy’s and St. Thomas’ NHS Foundation Trust, London, ENG, United Kingdom
³GSK plc, Collegeville, PA
⁴GlaxoSmithKline, Collegeville, PA
⁵GSK, Baar, Switzerland
⁶Sierra Oncology, San Mateo, CA
⁷Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, NC

Claire N Harrison¹, Alessandro Maria Vannucchi², Christian Recher, MD, PhD^3*, Francesco Passamonti, MD^4*, Aaron T. Gerds, MD, MS⁵, Juan Carlos Hernandez Boluda, MD, PhD^6*, Abdulraheem Yacoub, MD^7*, Shireen Sirhan, MD^8*, Jun Kawashima, MD^9*, Bharat Patel, BSc^10*, Bryan Strouse, MS^10* and Uwe Platzbecker, MD^11*

¹Guy’s and St. Thomas’ NHS Foundation Trust, London, ENG, United Kingdom
²Department of Experimental and Clinical Medicine, Centro di Ricerca e Innovazione Malattie Mieloproliferative (CRIMM), AOU Careggi, University of Florence, Firenze, Italy
³IUCT-Oncopole, Hematology Department, CHU Toulouse, Toulouse, France
⁴University of Milano Statale, Milano, Italy
⁵Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
⁶Hospital Clínico Universitario-INCLIVA, Valencia, Spain
⁷The University of Kansas Clinical Cancer Research Center, Leawood, KS
⁸Gerald Bronfman Department of Oncology, McGill University, Montreal, Canada
⁹Sierra Oncology, a GSK company, San Mateo, CA
¹⁰GSK plc, Collegeville, PA
¹¹University Hospital of Leipzig, Leipzig, Germany

Naveen Pemmaraju, MD¹, Alina Markova, MD², Lucia Masarova, MD¹, Nancy Reaven^3*, Susan Funk^3*, Pedro Oyuela, MD^4*, Frank Valone, MD^4*, Phil Dinh^4*, Lucy Bellamy^4*, Nikita Modi, PharmD^4*, Arturo Molina, MD, MS, FACP⁴ and Suneel Gupta, PhD⁴

¹Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
²Memorial Sloan Kettering Cancer Center, New York, NY
³Strategic Health Resources, La Canada, CA
⁴Protagonist Therapeutics, Inc., Newark, CA

Kazuya Shimoda, MD, PhD¹, Hideo Yasunaga, MD, PhD^2*, Yuka Sugimoto, MD, PhD³, Hidetoshi Uenaka, PhD^4*, Takeo Dochi, PhD^5* and Gyungjin Jun, MSc^5*

¹University of Miyazaki, Miyazaki, Japan
²Department of Clinical Epidemiology and Health Economics, School of Public Health, The University of Tokyo, Tokyo, Japan
³Department of Hematology and Oncology, Mie University, Tsu City, Mie Prefecture, Japan
⁴Real World Data, Co., Ltd, Kyoto, Japan
⁵Medical Affairs Hematology Medical, Novartis Pharma K.K., Tokyo, JPN

Anand Ashwin Patel, MD¹, James J. Yoon, MD², Hannah Johnston, MD³, Marta Beata Davidson, MD, PhD⁴, Auro Viswabandya, MD⁵, Rory M. Shallis, MD⁶, Evan C. Chen, MD⁷, Madelyn Burkart, MD⁸, Timothy S. Oh, MD^8*, Sunil G. Iyer, MD⁹, Ellen Madarang, PharmD^10*, Chandrasekar Muthiah, MD¹¹, Raven Dean^12*, Joshua Kassner, MD^13*, Raajit K. Rampal, MD, PhD¹⁴, Guru Subramanian Guru Murthy, MD^15*, Terrence Bradley, MD¹⁶, Yasmin Abaza, MD¹⁷, Jacqueline S. Garcia, MD¹⁸, Vikas Gupta, MD¹⁹, Kristen Marie Pettit, MD²⁰, John Cursio, PhD^21* and Olatoyosi Odenike²²

¹Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, IL
²University of Michigan, Ann Arbor, MI
³Department of Medicine, University of Chicago, Chicago, IL
⁴Leukemia program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, ON, Canada
⁵University Health Network / Princess Margaret Cancer Centre, Toronto, ON, Canada
⁶Section of Hematology, Department of Internal Medicine, Yale School of Medicine, Yale University, New Haven, CT
⁷Dana Farber Cancer Institute, Boston, MA
⁸Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL
⁹Division of Hematology and Oncology, Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY
¹⁰University of Miami Sylvester Comprehensive Cancer Center, Miami, FL
¹¹Department of Internal Medicine, Medical College of Wisconsin, Wauwatosa, WI
¹²University of Chicago Comprehensive Cancer Center, Chicago, IL
¹³Department of Internal Medicine, New York-Presbyterian/Weill Cornell Medical Center, New York, NY
¹⁴Memorial Sloan Kettering Cancer Center, New York, NY
¹⁵Division of Hematology/Oncology, Medical College of Wisconsin, Milwaukee, WI
¹⁶University of Miami Sylvester Comprehensive Cancer Center, Miami, FL, USA, Miami, FL
¹⁷Division of Hematology and Oncology, Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, IL
¹⁸Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
¹⁹Leukemia Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
²⁰Rogel Cancer Center, University of Michigan, Ann Arbor, MI
²¹University of Chicago Biological Sciences Division, Chicago, IL
²²The University of Chicago Medicine and Comprehensive Cancer Center, Chicago, IL

Erin Peckham-Gregory, PhD, MPH^1*, Priya Bhatia Shetty, PhD, MS^1*, Erik Stricker, PhD^1*, Danielle Mitchell^1*, Howard Lin^1*, Brooks Scull^1*, Erik Ehli^2*, Christel Davis^2*, Kenneth L. McClain, MD, PhD³, Philip J. Lupo, PhD^4*, Carl E Allen, MD¹ and Michael E. Scheurer, PhD⁵

¹Baylor College of Medicine, Houston, TX
²Avera Institute for Human Genetics, Sioux Falls, SD
³Texas Childrens Cancer and Hematology Centers, Houston, TX
⁴Division of Hematology-Oncology, Department of Pediatrics, Baylor College of Medicine, Houston, TX
⁵Department of Pediatrics, Baylor College of Medicine, Houston, TX

Maymona Abdelmagid^1*, Jeanne Palmer, MD², James M. Foran, MD³, Aref Al-Kali, MD⁴, Omer Karrar^4*, Kaaren K. Reichard, MD⁵, Animesh D. Pardanani, MBBS, PhD⁴, Naseema Gangat, MBBS⁴ and Ayalew Tefferi, MD⁴

¹Division of Hematology, Mayo Clinic, Rochester, MN, USA., Rochester, MN
²Mayo Clinic - Arizona, Scottsdale, AZ
³Hematology/Oncology, Mayo Clinic, Jacksonville, FL
⁴Division of Hematology, Mayo Clinic, Rochester, MN
⁵Division of Hematopathology, Mayo Clinic, Rochester, MN

Ruben A. Mesa, MD¹, Vikas Gupta, MD², John Mascarenhas, MD^3*, Gabriella Hobbs, MD^4*, Jean-Jacques Kiladjian, MD, PhD⁵, Giacomo Coltro, MD^6*, Vincenzo Bagnardi, PhD^7*, Chiara Oriecuia, PhD^8*, Lennart Kann, PhD^9*, Gozde Colak, PhD^10*, Claire N Harrison¹¹ and Debarshi Dey, MD, PhD, MPH^10*

¹Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Wake Forest University School of Medicine, Winston-Salem, NC
²Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
³Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY
⁴Division of Hematology/Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA
⁵Clinical Investigation Center, Hôpital Saint-Louis, Université de Paris, Paris, France
⁶Azienda Ospedaliero Universitaria Careggi, University of Florence, Florence, Italy
⁷Department of Statistics and Quantitative Methods, University of Milano-Bicocca, Milan, Italy
⁸Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy
⁹MorphoSys AG, Planegg, Germany
¹⁰Constellation Pharmaceuticals, a MorphoSys Company, Boston, MA
¹¹Guy’s and St. Thomas’ NHS Foundation Trust, London, ENG, United Kingdom

Johannes Luebke, MD^1*, Anna Hohneck, MD^2,3*, Jan Leipe, MD^4*, Nicole Naumann, PhD^1*, Alice Fabarius, PhD^1*, Wolf-Karsten Hofmann, MD¹, Georgia Metzgeroth, MD^1*, Theano Papavassilu, MD^2,3*, Andreas Reiter, MD⁵ and Juliana Schwaab^6*

¹Department of Hematology and Oncology, University Hospital Mannheim, Heidelberg University, Mannheim, Germany
²Department of Cardiology, Angiology, Haemostaseology and Medical Intensive Care, University Hospital Mannheim, Heidelberg University, Mannheim, Germany
³European Center for AngioScience (ECAS) and German Center for Cardiovascular Research (DZHK) partner site Heidelberg/Mannheim, Mannheim, Germany
⁴Department of Nephrology, Immunology and Rheumatology, University Hospital Mannheim, Heidelberg University, Mannheim, Germany
⁵Department of Hematology and Oncology, University Medical Centre Mannheim, Mannheim, Germany
⁶Department of Hematology and Oncology, Iii.Medizinische Klinik, Mannheim, Germany

Long Chang^1,2*, Lin He^1,2*, Huacong Cai, MD^1,2*, Minghui Duan^2,3*, Jian Li^2,4*, Daobin Zhou, MD^1,2*, Gaurav Goyal, MD⁵ and Xinxin Cao^1,2*

¹Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China
²State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Beijing, China
³Department of Hematology, Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China
⁴Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
⁵Division of Hematology/Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL

Katie Erdos^1*, Madhu M Ouseph, MD, MBBS, PhD^2*, Julia Geyer, MD^2*, Neville Lee Jr.^1*, Ghaith Abu-Zeinah, MD¹, Joseph M. Scandura, MD, PhD, MS¹ and Richard T. Silver, MD¹

¹Richard T. Silver, MD Myeloproliferative Neoplasms Center, Weill Cornell Medicine, New York, NY
²Department of Pathology and Laboratory Medicine, Weill Cornell Medicine/New York Presbyterian Hospital, New York, NY

Daichi Sajiki^1*, Manabu Wakamatsu, MD.PhD^1*, Hideki Muramatsu, MD, PhD¹, Yusuke Tsumura, MD^1*, Daiki Yamashita, MD^1*, Ryo Maemura, MD^1*, Ayako Yamamori, MD, PhD^1*, Kotaro Narita, MD, PhD^1*, Shinsuke Kataoka, MD, PhD^1*, Atsushi Narita, MD, PhD^1*, Noriko Shimasaki, MD, PhD¹, Nobuhiro Nishio, MD, PhD^1,2* and Yoshiyuki Takahashi, MD, PhD¹

¹Department of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan
²Department of Advanced Medicine, Nagoya University Hospital, Nagoya, Japan

Hannah Goulart, MD^1*, Dahniel L Sastow, MD², Nicholas Dreher, BA^1*, Metodi Balev, BA^1*, Grace Van Hyfte^3*, Marina Kremyanskaya, MD, PhD⁴, Ronald Hoffman, MD⁵, John Mascarenhas, MD^5* and Douglas Tremblay, MD⁶

¹Mount Sinai Hospital, New York
²Mount Sinai Hospital, New York, NY
³Tisch Cancer Institute, The Mount Sinai Hospital, New York, NY
⁴Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY
⁵Department of Medicine, Division of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY
⁶Department of Hematology and Medical Oncology, Mount Sinai School of Medicine, New York, NY

Wenyu Yang^1*, Yunlong Chen^1*, Chenmeng Liu^2*, Jingliao Zhang, MD¹ and Xiaofan Zhu^3*

¹Pediatric Blood Diseases Center, State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences, Tianjin, China
²State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, CAMS & PUMC 2.Tianjin Institutes of Health Science, Tianjin, China
³Pediatric Blood Diseases Center, State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical Colleg, Tianjin, China

Andrew Tiu, MD¹, Zoe McKinnell, MD², Puneet Gill, BA^3*, Martha Antonio, BSN^3*, Zoe Shancer^4*, Nandan Srinivasa^5*, Shanshan Liu, MS, MPH^6*, Guoqing Diao, PhD^6*, Ramesh Subrahmanyam, PhD^7*, Craig Kessler, MD⁸ and Maneesh Rajiv Jain, MD⁷

¹Division of Hematology-Oncology, Lombardi Comprehensive Cancer Center, MedStar Georgetown University Hospital, Washington, DC
²Division of Hematology/Oncology, The George Washington University, Washington, DC
³Institute for Clinical Research, Washington DC VA Medical Center, Washington, DC
⁴The George Washington University, Washington, DC
⁵George Washington University School of Medicine, Washington, DC
⁶Department of Biostatistics and Bioinformatics, Milken Institute School of Public Health, George Washington University, Washington, DC
⁷Washington DC VA Medical Center, Washington, DC
⁸Lombardi Comprehensive Cancer Center, MedStar Georgetown University Hospital, Washington, DC

Orly Leiva, BS¹, Jose Alvarez-Cardona, MD^2*, Andrew M. Brunner, MD³, Chi-Joan How, MD⁴ and Gabriela S. Hobbs, MD⁵

¹New York University Grossman School of Medicine, Boston, MA
²New York University Grossman School of Medicine, New York City
³Division of Hematology/Oncology, Dana-Farber Cancer Institute, Boston, MA
⁴Internal Medicine - Hematology, Brigham and Women's Hospital, Somerville, MA
⁵Division of Hematology/Oncology, Massachusetts General Hospital, Boston, MA

Claire N Harrison¹, Ruben A. Mesa, MD², Moshe Talpaz, MD³, Haifa Kathrin Al-Ali^4*, Blanca Xicoy, MD^5*, Francesco Passamonti, MD^6*, Francesca Palandri, MD^7*, Giulia Benevolo, MD^8*, Alessandro M. Vannucchi, MD^9*, Clemence Mediavilla, MD^10*, Alessandra Iurlo, MD, PhD^11*, InHo Kim^12*, Patrick Brown^13*, Christopher Hernandez^13*, Shelonitda Rose^13*, Jia Wang^13* and Jean-Jacques Kiladjian^14*

¹Guy’s and St. Thomas’ NHS Foundation Trust, London, ENG, United Kingdom
²Wake Forest University School of Medicine, Winston-Salem, NC
³University of Michigan Cancer Center, Ann Arbor, MI
⁴Universitätsklinikum Halle, Saale, Germany
⁵Institut Català d’Oncologia-Hospital Universitari Germans Trias i Pujol (HUGTP) -Josep Carreras Leukemia Research Institute, Universitat Autònoma de Barcelona, Barcelona, Spain
⁶University of Milano Statale, Milan, Italy
⁷IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia “Seràgnoli”, Bologna, Italy
⁸University Hematology Division, A.O.U. Città de Salute e Scienza, Torino, Italy
⁹A.O.U. Careggi, Universita di Firenze, Florence, Italy
¹⁰Hopital Haut-Leveque, Bordeaux, France
¹¹Hematology Division, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy
¹²Seoul National University Hospital, Seoul, Korea, Republic of (South)
¹³Bristol Myers Squibb, Princeton, NJ
¹⁴Hospital Saint Louis and University Paris Cité, Paris, France

Vikas Gupta, MD, FRCP^1*, Ciprian Tomuleasa^2,3,4*, Gilberto Israel Barranco Lampon^5*, Hsin-An Hou^6*, Grzegorz Helbig, MD, PhD^7*, Argiris S. Symeonidis, MD, PhD⁸, Ibrahim Haznedaroglu^9*, Kenny Galvez^10*, Fernando Tatsch^11*, Avijeet S Chopra^12*, Meng Zhang^11*, Tamas Vizkelety^11* and David M Ross^13*

¹Princess Margaret Cancer Centre, Toronto, ON, Canada
²Department of Hematology, Ion Chiricuta Clinical Cancer Center,, Cluj-Napoca, Romania
³Department of Hematology, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania
⁴Medfuture Research Center for Advanced Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania
⁵Hematology, Hospital General De México, Mexico City, Mexico
⁶Division of Hematology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan
⁷Department of Hematology and Bone Marrow Transplantation, Medical University of Silesia, Katowice, Poland
⁸Hematology Division Department of Internal Medicine, University of Patras, Patras, Greece
⁹Department of Hematology, Hacettepe University, Faculty of Medicine, Ankara, Turkey
¹⁰Hospital Pablo Tobón Uribe, Medellín, Colombia
¹¹AbbVie, Inc., North Chicago, IL
¹²AbbVie Inc., North Chicago, IL
¹³Royal Adelaide Hospital and Flinders Medical Centre, Adelaide, SA, Australia

Jen-Chin Wang, MD¹, Guanfang Shi^1*, Ladan Enayati, MD^1*, Ching Wong, MD^2* and Gardith Joseph, MD^1*

¹Division of Hematology/Oncology, Brookdale University Hospital and Medical Center, Brooklyn, NY
²Division of Hematology/Oncology, NYU Langone Hospital-Brooklyn, Brooklyn, NY

Helen Ajufo, MD, MS¹, Jan Philipp Bewersdorf, MD¹, Claire N Harrison², Francesca Palandri, MD^3*, John Mascarenhas, MD^4*, Jeanne Palmer, MD⁵, Aaron T. Gerds, MD, MS⁶, Jean-Jacques Kiladjian, MD, PhD⁷, Sarah Buckley, MD^8*, Andriy Derkach, PhD^9*, Karisse Roman-Torres^8* and Raajit K. Rampal, MD, PhD¹

¹Memorial Sloan Kettering Cancer Center, New York, NY
²Guy's and St. Thomas' NHS Foundation Trust, London, United Kingdom
³IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia “Seràgnoli”, Bologna, Italy, Bologna, Italy
⁴Department of Medicine, Division of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY
⁵Mayo Clinic, Phoenix, AZ
⁶Cleveland Clinic Taussig Cancer Institute, Cleveland, OH
⁷Hôpital Saint-Louis, Université de Paris, Paris, France
⁸CTI BioPharma Corp., a Sobi company, Seattle, WA
⁹Department of Biostatistics and Epidemiology, Memorial Sloan Kettering Cancer Center, New York, NY

Yelena Ginzburg, MD¹, Lee Ping Chew, MD, MRCP^2*, Nikita Modi, PharmD^3*, Suneel Gupta, PhD³, Arturo Molina, MD, MS, FACP³ and Nishit B. Modi, PhD^3*

¹Division of Hematology & Medical Oncology, Tisch Cancer Institute/ Icahn School of Medicine at Mount Sinai, New York, NY
²Hospital Umum Sarawak, Sarawak, Malaysia
³Protagonist Therapeutics, Inc., Newark, CA

Keri Maher, DO¹, Raajit K. Rampal, MD, PhD², Prithviraj Bose, MD³, Nikolai A. Podoltsev, MD, PhD⁴, Claire N Harrison⁵, Junshik Hong, MD⁶, Xulong Wang^7*, Kamal Chamoun^7* and John Mascarenhas, MD^8*

¹Massey Cancer Center, Virginia Commonwealth University, Richmond, VA
²Memorial Sloan Kettering Cancer Center, New York, NY
³MD Anderson Cancer Center, The University of Texas, Houston, TX
⁴Associate Professor of Medicine, Department of Hematology, Yale School of Medicine, New Haven, CT
⁵Guy’s and St. Thomas’ NHS Foundation Trust, London, ENG, United Kingdom
⁶Seoul National University Hospital, Seoul National University College of Medicine, Seoul, KOR
⁷Karyopharm Therapeutics, Newton, MA
⁸Department of Medicine, Division of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY

Elliot Stieglitz, MD¹, Yueh-Yun Chi, PhD^2*, Bill H. Chang, MD, PhD³, Sarah K Tasian, MD⁴, Marielle Yohe, MD, PhD^5*, Christopher C Dvorak, MD⁶, Erica Southworth, NP^1*, Janel R. Long-Boyle, PhD, PharmD^7*, Jessica Van Ziffle, PhD^1*, Zied Abdullaev, PhD^5*, Roy Leong^8*, Alan S. Wayne, MD⁸, Deepa Bhojwani, MD⁸ and Mignon L. Loh, MD⁹

¹University of California, San Francisco, San Francisco, CA
²Biostatistics, Children's Hospital of Los Angeles, Los Angeles, CA
³OHSU, Portland, OR
⁴Children's Hospital of Philadelphia, Philadelphia, PA
⁵National Institute of Health, Bethesda, MD
⁶University of California San Francisco, San Francisco, CA
⁷Department of Clinical Pharmacy, University of California San Francisco, San Francisco, CA
⁸Children's Hospital of Los Angeles, Los Angeles, CA
⁹Ben Towne Center for Childhood Cancer Research, Seattle Children’s Hospital, Seattle, WA

Joseph M. Scandura, MD, PhD, MS¹, Aaron T. Gerds, MD, MS², Ellen K. Ritchie, MD³, Xulong Wang^4*, Steve Kye^4* and Raajit K. Rampal, MD, PhD⁵

¹Weill Cornell Medical College, New York, NY
²Cleveland Clinic, Cleveland, OH
³Division of Hematology and Medical Oncology, Weill Cornell Medicine/New York Presbyterian Hospital, New York, NY
⁴Karyopharm Therapeutics, Newton, MA
⁵Memorial Sloan Kettering Cancer Center, New York, NY